Showing 1 to 2 of 2 results


Five Years of "Sputnik V": A COVID-19 Vaccine's Impact on Global Health
Sputnik V," Russia's adenovirus-based COVID-19 vaccine, registered five years ago on August 11, 2025, achieved over 90% efficacy in clinical trials, saving tens of thousands of lives and influencing global vaccine development, despite initial skepticism and reduced effectiveness against later Omicro...
Five Years of "Sputnik V": A COVID-19 Vaccine's Impact on Global Health
Sputnik V," Russia's adenovirus-based COVID-19 vaccine, registered five years ago on August 11, 2025, achieved over 90% efficacy in clinical trials, saving tens of thousands of lives and influencing global vaccine development, despite initial skepticism and reduced effectiveness against later Omicro...
Progress
60% Bias Score

Gamaleya Institute's mRNA Cancer Vaccine Shows Promise in Preclinical Trials
Preclinical trials of Gamaleya Research Institute's mRNA melanoma vaccine show tumor and metastasis regression in animals; human trials are planned for autumn 2025, initially combining the vaccine with other therapies for advanced cancers; future development aims for personalized, affordable vaccine...

Gamaleya Institute's mRNA Cancer Vaccine Shows Promise in Preclinical Trials
Preclinical trials of Gamaleya Research Institute's mRNA melanoma vaccine show tumor and metastasis regression in animals; human trials are planned for autumn 2025, initially combining the vaccine with other therapies for advanced cancers; future development aims for personalized, affordable vaccine...
Progress
56% Bias Score
Showing 1 to 2 of 2 results